Literature DB >> 15449054

Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer-rarity of co-occurrence of mutations in APC, K-ras, and p53 genes.

Jy-Ming Chiang1, Yah-Huei Wu Chou, Shih-Chieh Ma, Jim-Ray Chen.   

Abstract

INTRODUCTION: Previous studies have investigated the possibility that specific mutations may be related to specific clinicopathological features. However, most previous investigations included only an average age (40-80 years) group of sporadic colorectal cancers and, moreover, studied only a single gene in isolation. Therefore, the influence of age on these mutation frequencies remains unclear, despite age being considered a risk factor for genetic mutation.
MATERIALS AND METHODS: This study included 122 sporadic colorectal cancers from three different age groups and analyzed mutation frequencies of adenomatous polyposis coli (APC), K-ras, and p53 genes and microsatellite instability to determine their mutation frequencies and relationships with clinicopathological features.
RESULTS: Significantly lower p53 mutation frequencies were observed among young (32 years old or younger) and old (86 years old or older) patient groups compared with an average age (39-85 years old) patient group (14.3% and 19.2% versus 51.5%, P<0.001). APC mutation frequency (11.8%) was significantly lower in highly aggressive (Dukes' stage D) tumors ( P=0.003) than in the other stage tumors (Dukes' stage A, B, and C). Additionally, simultaneous occurrence of all three genetic alterations in an individual tumor was rare (below 5%). Statistical analysis further confirmed that mutation number in Dukes' D tumors occurred less frequently than expected in other stage tumors ( P=0.008).
CONCLUSIONS: Genetic alterations of sporadic colorectal cancers have different relationships with age or tumor stage. Additionally, most sporadic colorectal tumors do not necessarily require following the widely accepted genetic model, because the three key genetic mutations, APC, K-ras, and p53, rarely occur simultaneously.

Entities:  

Mesh:

Year:  2004        PMID: 15449054     DOI: 10.1007/s00428-004-1116-z

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  38 in total

1.  Prognostic significance of p53 mutations in colon cancer at the population level.

Authors:  Wade S Samowitz; Karen Curtin; Khe-ni Ma; Sandra Edwards; Donna Schaffer; Mark F Leppert; Martha L Slattery
Journal:  Int J Cancer       Date:  2002-06-01       Impact factor: 7.396

2.  Ki-ras oncogene and p53 tumour suppressor gene mutations in colorectal carcinomas from the European Saar-Luxembourg region are less frequent than predicted by the classic adenoma-carcinoma sequence model.

Authors:  M Pauly; M Schmitz; I Kayser; O Türeci; P Lagoda; G Seitz; M Dicato
Journal:  Eur J Cancer       Date:  1997-11       Impact factor: 9.162

3.  Mutations of the APC gene in human sporadic colorectal cancers.

Authors:  C De Filippo; C Luceri; G Caderni; M Pacini; L Messerini; A Biggeri; E Mini; F Tonelli; F Cianchi; P Dolara
Journal:  Scand J Gastroenterol       Date:  2002-09       Impact factor: 2.423

4.  Reappraisal of K-ras and p53 gene mutations in the recurrence of Dukes' B2 rectal cancer after curative resection.

Authors:  J T Liang; Y M Cheng; K J Chang; C T Chien; H C Hsu
Journal:  Hepatogastroenterology       Date:  1999 Mar-Apr

Review 5.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

Authors:  C R Boland; S N Thibodeau; S R Hamilton; D Sidransky; J R Eshleman; R W Burt; S J Meltzer; M A Rodriguez-Bigas; R Fodde; G N Ranzani; S Srivastava
Journal:  Cancer Res       Date:  1998-11-15       Impact factor: 12.701

6.  Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.

Authors:  Gillian Smith; Francis A Carey; Julie Beattie; Murray J V Wilkie; Tracy J Lightfoot; Jonathan Coxhead; R Colin Garner; Robert J C Steele; C Roland Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

7.  Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test.

Authors:  R van der Luijt; P M Khan; H Vasen; C van Leeuwen; C Tops; P Roest; J den Dunnen; R Fodde
Journal:  Genomics       Date:  1994-03-01       Impact factor: 5.736

8.  Genetic instability occurs in the majority of young patients with colorectal cancer.

Authors:  B Liu; S M Farrington; G M Petersen; S R Hamilton; R Parsons; N Papadopoulos; T Fujiwara; J Jen; K W Kinzler; A H Wyllie; B Vogelstein; M G Dunlop
Journal:  Nat Med       Date:  1995-04       Impact factor: 53.440

9.  p53 and behaviour of colorectal cancer.

Authors:  H S Goh; C S Chan; K Khine; D R Smith
Journal:  Lancet       Date:  1994-07-23       Impact factor: 79.321

10.  Nuclear beta-catenin expression is closely related to ulcerative growth of colorectal carcinoma.

Authors:  J M Chiang; Y H Wu Chou; T C Chen; K F Ng; J L Lin
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

View more
  4 in total

1.  Implication of K-ras and p53 in colorectal cancer carcinogenesis in Tunisian population cohort.

Authors:  Chaar Ines; Ounissi Donia; Boughriba Rahma; Azza Ben Ammar; Amara Sameh; Taher Khalfallah; Ben Hmida Abdelmajid; Mzabi Sabeh; Bouraoui Saadia
Journal:  Tumour Biol       Date:  2014-04-25

2.  RAS/RAF/MEK/ERK and PI3K/PTEN/AKT Signaling in Malignant Melanoma Progression and Therapy.

Authors:  Ichiro Yajima; Mayuko Y Kumasaka; Nguyen Dinh Thang; Yuji Goto; Kozue Takeda; Osamu Yamanoshita; Machiko Iida; Nobutaka Ohgami; Haruka Tamura; Yoshiyuki Kawamoto; Masashi Kato
Journal:  Dermatol Res Pract       Date:  2011-10-12

3.  Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.

Authors:  E Miranda; A Destro; A Malesci; E Balladore; P Bianchi; E Baryshnikova; G Franchi; E Morenghi; L Laghi; L Gennari; M Roncalli
Journal:  Br J Cancer       Date:  2006-09-12       Impact factor: 7.640

4.  The role of kras mutations and MSI status in diagnosis of colorectal cancer.

Authors:  Atena Irani Shemirani; Mahdi Montazer Haghighi; Saman Milanizadeh; Mohammad Yaghoob Taleghani; Seyed Reza Fatemi; Behzad Damavand; Zahra Akbari; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2011
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.